Shares of Ligand Pharmaceuticals Incorporated (LGND) are rallying more than 21 percent Tuesday morning after reporting upbeat fourth-quarter results, above analysts' view.
Net income from continuing operations for the fourth quarter was $18.2 million, or $1.03 per share, compared with a net loss of $14.5 million, or $0.86 per share, for the same period a year ago.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com